» Articles » PMID: 28369163

Estimating Direct and Indirect Protective Effect of Influenza Vaccination in the United States

Overview
Journal Am J Epidemiol
Specialty Public Health
Date 2017 Apr 4
PMID 28369163
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

With influenza vaccination rates in the United States recently exceeding 45% of the population, it is important to understand the impact that vaccination is having on influenza transmission. In this study, we used a Bayesian modeling approach, combined with a simple dynamical model of influenza transmission, to estimate this impact. The combined framework synthesized evidence from a range of data sources relating to influenza transmission and vaccination in the United States. We found that, for seasonal epidemics, the number of infections averted ranged from 9.6 million in the 2006-2007 season (95% credible interval (CI): 8.7, 10.9) to 37.2 million (95% CI: 34.1, 39.6) in the 2012-2013 season. Expressed in relative terms, the proportion averted ranged from 20.8% (95% CI: 16.8, 24.3) of potential infections in the 2011-2012 season to 47.5% (95% CI: 43.7, 50.8) in the 2008-2009 season. The percentage averted was only 1.04% (95% CI: 0.15, 3.2) for the 2009 H1N1 pandemic, owing to the late timing of the vaccination program in relation to the pandemic in the Northern hemisphere. In the future, further vaccination coverage, as well as improved influenza vaccines (especially those offering better protection in the elderly), could have an even stronger effect on annual influenza epidemics.

Citing Articles

Evaluating the effectiveness of vaccination campaigns: Insights from unvaccinated mortality data.

Lin L, Demirhan H, Stone L Infect Dis Model. 2025; 10(1):365-373.

PMID: 39803368 PMC: 11719296. DOI: 10.1016/j.idm.2024.12.004.


Direct and indirect effects of hepatitis B vaccination in four low- and middle-income countries.

de Villiers M, de Villiers E, Nayagam S, Hallett T Epidemics. 2024; 49:100798.

PMID: 39541625 PMC: 11649532. DOI: 10.1016/j.epidem.2024.100798.


Evaluating the COVID-19 vaccination program in Japan, 2021 using the counterfactual reproduction number.

Kayano T, Ko Y, Otani K, Kobayashi T, Suzuki M, Nishiura H Sci Rep. 2023; 13(1):17762.

PMID: 37853098 PMC: 10584853. DOI: 10.1038/s41598-023-44942-6.


Coverage and impact of influenza vaccination among children in Minhang District, China, 2013-2020.

Zhang Z, Shi L, Liu N, Jia B, Mei K, Zhang L Front Public Health. 2023; 11:1193839.

PMID: 37711236 PMC: 10499390. DOI: 10.3389/fpubh.2023.1193839.


Impact of SARS-CoV-2 vaccination of children ages 5-11 years on COVID-19 disease burden and resilience to new variants in the United States, November 2021-March 2022: A multi-model study.

Borchering R, Mullany L, Howerton E, Chinazzi M, Smith C, Qin M Lancet Reg Health Am. 2022; 17:100398.

PMID: 36437905 PMC: 9679449. DOI: 10.1016/j.lana.2022.100398.


References
1.
Janaszek W, Gay N, Gut W . Measles vaccine efficacy during an epidemic in 1998 in the highly vaccinated population of Poland. Vaccine. 2003; 21(5-6):473-8. DOI: 10.1016/s0264-410x(02)00482-6. View

2.
Palese P . Influenza: old and new threats. Nat Med. 2004; 10(12 Suppl):S82-7. DOI: 10.1038/nm1141. View

3.
Rudenko L, Slepushkin A, Monto A, Kendal A, Grigorieva E, Burtseva E . Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod, Russia. J Infect Dis. 1993; 168(4):881-7. DOI: 10.1093/infdis/168.4.881. View

4.
van den Driessche P, Watmough J . Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission. Math Biosci. 2002; 180:29-48. DOI: 10.1016/s0025-5564(02)00108-6. View

5.
Xu R, Ekiert D, Krause J, Hai R, Crowe Jr J, Wilson I . Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus. Science. 2010; 328(5976):357-60. PMC: 2897825. DOI: 10.1126/science.1186430. View